IsoRay (ISR) – Hot Corp. News
-
IsoRay (ISR) Confirms FDA Clearance of GammaTile Therapy for Treatment of Recurrent Brain Neoplasms
-
IsoRay (ISR) Reports Published Study on the Impact of Permanent Low-Dose Rate Cesium-131 Brachytherapy on Local Control & Radionecrosis in Patients Treated for Large Brain Metastases
-
-
-
-
-
-
-
-
-
-
-
Back to ISR Stock Lookup